The BCL2L2 of the Bcl-2 family is an important anti-apoptotic gene [58], and suppression of its expression sensitizes cells to anticancer drugs [59]–[60], whereas MT1F exerts its tumor-suppressive ability by inducing apoptosis [61]. Here, BCL2L2 is linked to neoplasm.